BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Genetown

  Organ-on-a-Chip Company Emulate Closes on $36 Million Series C Financing

  Boston-based Emulate closed on a Series C round worth $36 million.

  June 19, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  CF Drugmaker Vertex More Than Doubles R&D Space in San Diego

  Vertex Pharmaceuticals has substantially expanded the San Diego-based research and development facility.

  June 19, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  FDA Hits Valeant’s Plaque Psoriasis Drug with a Complete Response Letter

  Ortho Dermatologics, a division of Quebec-based Valeant Pharmaceuticals International, received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for Duobrii for plaque psoriasis.

  June 19, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  Pharma Companies Secure About $250 Million in Financing Today

  Venture capitalists are flexing their muscles today with the significant support of pharma and biotech companies.

  June 19, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Biotechnology Institute Award’s 2018 Woman of the Year Award to J&J’s Seema Kumar

  The Biotechnology Institute gave its newly launched 2018 Woman of the Year Award to Seema Kumar.

  June 19, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  Array Hope Rises as Potential FDA Approval of Melanoma Treatment Nears

  Array is anxiously awaiting the FDA to approve its combination treatment for BRAF-mutant metastatic melanoma. If approved, Chief Executive Officer Ron Squarer believes it will not only be an important milestone for the company, but also for the patients.

  June 19, 2018

   · 

  3 min read

   · 

  Alex Keown
• 

  Deals

  Roche Acquires Remaining Shares of Foundation Medicine for $2.4 Billion

  Three years after acquiring a majority stake Foundation Medicine, Pharma giant Roche has agreed to buy up all outstanding shares for about $2.4 billion and bring the company’s sequencing diagnostics platform under the Roche umbrella.

  June 19, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Kallyope and Novo Nordisk Team Up To Tackle Obesity

  New York-based Kallyope and Danish company Novo Nordisk A/S signed a research collaboration and option deal to discover novel therapeutics to treat obesity and diabetes.

  June 19, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  Chinese Biotechs Flex Financial Muscles With Continued Investments

  Chinese companies and investors continue to flex their financial muscles with a series of deals this week that highlight the continued growing impact that country is having on the global pharmaceutical and biotech landscape.

  June 19, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Eloxx Pharmaceuticals Taps Celgene Veteran as Lead Attorney

  Eloxx Pharmaceuticals tapped Celgene veteran Neil Belloff as the company’s general counsel and corporate secretary.

  June 19, 2018

   · 

  2 min read

   · 

  Alex Keown